Lancet[journal] 检索结果

741. Resurgence of cholera amidst ongoing war in Sudan.

作者: Yousif Ali.;Emmanuel Edwar Siddig.;Ayman Ahmed.
来源: Lancet. 2024年404卷10464期1724-1725页

742. Research focus: GARDP.

作者: Talha Burki.
来源: Lancet. 2024年404卷10465期1800页

743. Climate crisis, cities, and health.

作者: Mark J Nieuwenhuijsen.
来源: Lancet. 2024年404卷10463期1693-1700页

744. Hypertrophic cardiomyopathy secondary to hydroxychloroquine toxicity in a patient with rheumatoid arthritis.

作者: Iside Cartella.;Matteo Palazzini.;Domenico Sirico.;Andrea Buono.;Duccio Petrella.;Fabrizio Oliva.;Andrea Garascia.;Enrico Ammirati.
来源: Lancet. 2024年404卷10462期1560页

745. Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.

作者: Amanda B Payne.;Janet A Watts.;Patrick K Mitchell.;Kristin Dascomb.;Stephanie A Irving.;Nicola P Klein.;Shaun J Grannis.;Toan C Ong.;Sarah W Ball.;Malini B DeSilva.;Karthik Natarajan.;Tamara Sheffield.;Daniel Bride.;Julie Arndorfer.;Allison L Naleway.;Padma Koppolu.;Bruce Fireman.;Ousseny Zerbo.;Julius Timbol.;Kristin Goddard.;Brian E Dixon.;William F Fadel.;Colin Rogerson.;Katie S Allen.;Suchitra Rao.;David Mayer.;Michelle Barron.;Sarah E Reese.;Elizabeth A K Rowley.;Morgan Najdowski.;Allison Avrich Ciesla.;Josephine Mak.;Emily L Reeves.;Omobosola O Akinsete.;Charlene E McEvoy.;Inih J Essien.;Mark W Tenforde.;Katherine E Fleming-Dutra.;Ruth Link-Gelles.
来源: Lancet. 2024年404卷10462期1547-1559页

Respiratory syncytial virus vaccines first recommended for use during 2023 were efficacious against lower respiratory tract disease in clinical trials. Limited real-world data regarding respiratory syncytial virus vaccine effectiveness are available. To inform vaccine policy and address gaps in evidence from the clinical trials, we aimed to assess the effectiveness against respiratory syncytial virus-associated hospitalisations and emergency department encounters among adults aged at least 60 years.

746. Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial.

作者: Anthony Rodgers.;Abdul Salam.;Aletta E Schutte.;William C Cushman.;H Asita de Silva.;Gian Luca Di Tanna.;Diederick E Grobbee.;Krzysztof Narkiewicz.;Dike B Ojji.;Neil R Poulter.;Markus P Schlaich.;Suzanne Oparil.;Wilko Spiering.;Bryan Williams.;Jackson T Wright.;P Lakshman.;W Uluwattage.;P Hay.;T Pereira.;N Amarasena.;G Ranasinghe.;Chris Gianacas.;Mathangi Shanthakumar.;Xiaoqiu Liu.;Nelson Wang.;Sonali R Gnanenthiran.;Paul K Whelton.; .
来源: Lancet. 2024年404卷10462期1536-1546页

Single-pill combinations (SPCs) of three low-dose antihypertensive drugs can improve hypertension control but are not widely available. A key issue for any combination product is the contribution of each component to efficacy and tolerability. This trial compared a new triple SPC called GMRx2, containing telmisartan, amlodipine, and indapamide, with dual combinations of components for efficacy and safety.

747. Nutritional supplementation for tuberculosis prevention: the RATIONS trial - Authors' reply.

作者: Anurag Bhargava.;Madhavi Bhargava.;Banurekha Velayutham.;Andrea Benedetti.
来源: Lancet. 2024年404卷10462期1524页

748. Nutritional supplementation for tuberculosis prevention: the RATIONS trial.

作者: Kehong Zhang.;Yuzhong Xu.;Yunlong Hu.;Xinchun Chen.
来源: Lancet. 2024年404卷10462期1523-1524页

749. Nutritional supplementation for tuberculosis prevention: the RATIONS trial.

作者: Jacob Busang.;Palwasha Khan.
来源: Lancet. 2024年404卷10462期1522-1523页

750. Nutritional supplementation for tuberculosis prevention: the RATIONS trial.

作者: Hannah M Rickman.;Tom A Yates.
来源: Lancet. 2024年404卷10462期1522页

751. Nutritional supplementation for tuberculosis prevention: the RATIONS trial.

作者: Manveen Kaur Jabinda.
来源: Lancet. 2024年404卷10462期1521-1522页

752. The politics of reform of NHS dentistry.

作者: Rebecca Harris.;Gary Lowery.;Stefan Listl.
来源: Lancet. 2024年404卷10462期1521页

753. The system is working as intended.

作者: Sara El-Solh.;Rhiannon Mihranian Osborne.
来源: Lancet. 2024年404卷10462期1520-1521页

754. Non-communicable disease management in reproductive health care.

作者: Youwen Mei.;Fang Wang.;Yonghong Lin.
来源: Lancet. 2024年404卷10462期1519-1520页

755. Human vaccination for highly pathogenic avian influenza.

作者: Francesco Branda.;Jiyeon Oh.;Krishna Prasad Acharya.;Dong Keon Yon.;Massimo Ciccozzi.;Fabio Scarpa.
来源: Lancet. 2024年404卷10462期1518-1519页

756. Shame competence: addressing the effects of shame in health care.

作者: Luna Dolezal.;William Bynum.
来源: Lancet. 2024年404卷10462期1514-1515页

757. Jean Nachega: collaborating for research on mpox in Africa.

作者: Udani Samarasekera.
来源: Lancet. 2024年404卷10462期1511页

758. Offline: Rethinking the human costs of climate change.

作者: Richard Horton.
来源: Lancet. 2024年404卷10462期1506页

759. Real-world effectiveness studies of the benefit of RSV vaccines.

作者: Angela R Branche.
来源: Lancet. 2024年404卷10462期1498-1500页

760. A novel low-dose triple single-pill combination for hypertension.

作者: Maria Antonopoulou.;Konstantinos Chliveros.
来源: Lancet. 2024年404卷10462期1496-1498页

结果排序

文献格式

出版时间

出版类型

出版语言